Double Wood GLP-1 Supplement (Eriomin)
Double Wood builds this around Eriomin, a branded lemon flavonoid ingredient, and states that across three randomised studies participants saw an average 17.5% increase in GLP-1 versus placebo. That is the first specific, checkable, quantified GLP-1 claim in this entire directory. It is also the clearest illustration of the gap between a supplement and a prescription GLP-1, because you can finally do the comparison with an actual figure.
Last reviewed · researched from the manufacturer’s published pages by Tom
What’s in it
Amounts are shown only where the manufacturer publishes them. Anything without a figure is undisclosed — and for an active ingredient, an undisclosed dose is the central problem with this category.
- Eriomin (lemon flavonoids)Amount not published in the product description we captured
A branded, clinically studied citrus flavonoid ingredient
How the manufacturer says it works
Double Wood states that Eriomin harnesses lemon flavonoids to support healthy GLP-1 function, and that across three randomised studies participants experienced an average increase of 17.5% in GLP-1 compared with placebo, concluding that Eriomin is effective at naturally supporting GLP-1 production and function. Non-GMO and gluten-free.
What the evidence actually supports
Give credit where it is due: this is a branded ingredient with actual randomised human trials behind it, and the company states the result as a specific percentage rather than gesturing at 'support'. Citrus flavonoids including eriocitrin have published research in prediabetic and metabolic populations. Quantifying the claim is exactly what we want manufacturers to do, because it makes the claim falsifiable rather than vague. The company also describes GLP-1's actual physiology accurately in its own product copy.
Where that evidence stops
Now use the number. A 17.5% increase in your own GLP-1, from a normal physiological baseline, is not in the same universe as a prescription GLP-1 receptor agonist — semaglutide and tirzepatide produce sustained, supraphysiological activation of the receptor, which is why they change body weight by double digits in percentage terms. A modest percentage rise in endogenous hormone is a real biological effect and a small one, and the trials measured hormone levels rather than weight outcomes. The quantity of Eriomin per capsule is not published in the description we captured, so you cannot confirm it matches the studied dose. Believe the 17.5% and understand what it does and does not buy you.
Strengths and problems
Strengths
- States a specific, quantified GLP-1 result (17.5% versus placebo) rather than vague 'support' language
- Uses a named, branded ingredient with published randomised human trials
- Describes GLP-1 physiology accurately in its own copy
- $19.95 is inexpensive for a branded clinically studied ingredient
- Non-GMO and gluten-free stated
- Double Wood publishes Supplement Facts panels on its product pages
Problems
- A 17.5% rise in your own GLP-1 is nothing like the receptor activation a prescription GLP-1 produces — the number makes that clear
- Eriomin quantity per capsule is not published in the description we captured, so the studied dose cannot be confirmed
- The trials measured hormone levels, not weight outcomes
- Directions, warnings and refunds are not published in the description we captured
- The product name invites exactly the comparison the evidence cannot support
What the manufacturer publishes
Publishes 8 of 8 standard terms.
- Intended use
- Sold as a dietary supplement, not as a treatment for any condition.
- Directions
- Not published in the product description we captured.
- Warnings
- Not published in the product description we captured.
- Allergens
- States non-GMO and gluten-free.
- Third-party testing
- Not stated in the product description we captured. Double Wood publishes Supplement Facts panel images on its product pages.
- Pricing
- $19.95 at capture.
- Subscription
- Not stated in the description we captured.
- Refunds
- Not stated in the description we captured.
- Shipping
- Free shipping on orders over $30 across the Double Wood range.
May suit
Someone who wants a branded, trial-backed ingredient at a low price and can read a 17.5% figure for what it is.
Do not use if
- You are expecting anything resembling prescription GLP-1 results
- You have a citrus allergy
- You are pregnant or breastfeeding without checking with a clinician
Frequently asked
Is a 17.5% GLP-1 increase a lot?
It is a real, measurable effect and a small one. Your own GLP-1 rises and falls around meals; a 17.5% average increase nudges that curve. A prescription GLP-1 receptor agonist bypasses the curve entirely and holds the receptor activated continuously at levels your body never produces. That is why one changes body weight by double-digit percentages and the other is sold as a supplement.
Why praise the claim and then pick it apart?
Because both are deserved. Publishing a specific percentage from randomised trials is far better practice than the vague 'supports healthy GLP-1' language everywhere else in this category. Having the number is what lets you see that the effect is modest. Vagueness would have hidden that.
Sources
Captured . Manufacturer pages change — check the current version before relying on anything.